Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects

Diabetes Care

Volumn 20, Issue 10, 1997, Pages 1562-1568

  Matsumoto, Kazunari ^a,c   Miyake, Seibei ^a   Yano, Mayumi ^a   Ueki, Yukitaka ^a   Yamaguchi, Yoshihiko ^b   Akazawa, Shoichi ^b   Tominaga, Yuko ^a  

^a Sasebo Chuou Hospital   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c Sasebo Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; JAPAN; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST;

EID: 0030843939     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.10.1562     Document Type: Article

References (33)

1. Arner P, Pollare T, Lithell H: Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and nonobese subjects. Diabetologia 34:483-487, 1991
2. Banerji MA, Lebovitz HE: Insulin-sensitive and insulin-resistant variants in NIDDM. Diabetes 38:784-792, 1989
3. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C: Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217-1225, 1988
4. Reaven GM, Hollenbeck CB, Chen YDI: Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52-55, 1989
5. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus. Results of a 25-year follow-up study. Lancet 340:925-929,1992
6. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395, 1989
7. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
8. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet I:1356-1359, 1989
9. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29, 1992
10. O'Rahilly SP, Nugent Z, Rudenski AS, Hosker JP, Burnett MA, Darling P, Turner RC: Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet 2:360-364, 1986
11. Porte D Jr: β-cells in type II diabetes mellitus. Diabetes 40:166-180, 1991
12. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with first-degree NIDDM relatives. JAMA 273:1855-1861, 1995
13. Polonsky KS: The β-cell in diabetes: from molecular genetics to clinical research. Diabetes 44:705-717, 1995
14. Zimmet PZ: Challenges in diabetes epidemiology: from West to the rest. Diabetes Care 15:232-252, 1992
15. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I, Tokuyama K: Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41:1540-1546, 1992
16. Taniguchi A, Nakai Y, Doi K, Fukushima M, Nagata I, Kawamura H, Imura H, Suzuki M, Tokuyama K: Glucose effectiveness in two subtypes within impaired glucose tolerance: a minimal model analysis. Diabetes 43:1211-1217, 1994
17. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, Takaku F, Kosaka K: Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26:44-49, 1984
18. World Health Organization: Diabetes Mellitus. Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
19. Kosaka K, Hagura R, Kuzuya T, Kuzuya N: Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range. Diabetologia 10:775-782, 1974
20. Kosaka K, Hagura R, Kuzuya T: Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 26:944-952, 1977
21. Yoneda H, Cha T, Ikegami H, Kawaguchi Y, Yamamoto Y, Tahara Y, Yamato E, Ogihara T: Analysis of early-phase insulin responses in nonobese subjects with mild glucose intolerance. Diabetes Care 15:1517-1521, 1992
22. Phillips DIW, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurement of insulin resistance and insulin secretion. Diabet Med 11:286-292, 1994
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
24. Tomono S, Kato N, Utsugi T, Ohno T, Shimizu M, Fukuda M, Itoh Y, Ishii C, Kawazu S: The role of insulin in coronary atherosclerosis. Diabetes Res Clin Pract 22: 117-122, 1994
25. Chen KW, Boyko EJ, Bergstrom RW, Leonetti DL, Newell-Morris L, Wahl PW, Fujimoto WY: Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. Diabetes Care 18:747-753, 1995
26. Granner DK, O'Brien RM: Molecular physiology and genetics of NIDDM: importance of metabolic staging. Diabetes Care 15:369-395, 1992
27. Cook JTE, Page RCL, Levy JC, Hammersley MS, Walravens EKN, Turner RC: Hyperglycemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function. Diabet Med 10:321-326, 1993
28. Swinburn BA, Gianchandani R, Saad MF, Lillioja S: In vivo b-cell function at the transition to early non-insulin-dependent diabetes mellitus. Metabolism 44:757-764, 1995
29. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
30. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386-1391, 1995
31. Eriksson KF, Lindgarde F: Poor physical fitness, and impaired early insulin response but late hyperinsulinemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia 39:573-579, 1996
32. Ludvilk B, Nolan JJ, Baloga J, Sacks D, Olefsky J: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44:1121-1125, 1995
33. Chen M, Bergman RN, Pacini G, Porte D Jr: Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased β-cell function. J Clin Endocrinol Metab 60:13-20, 1985